Loading…
Alkaline Phosphatase: A Biomarker of Cardiac Function in Pediatric Patients
Myocardial dysfunction and heart failure are common in pediatric patients with congenital and acquired heart disease. Alkaline phosphatase (AP) has been suggested as a biomarker for myocardial dysfunction after Fontan operation. We hypothesized that pediatric patients with myocardial dysfunction req...
Saved in:
Published in: | Pediatric cardiology 2017-04, Vol.38 (4), p.762-769 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Myocardial dysfunction and heart failure are common in pediatric patients with congenital and acquired heart disease. Alkaline phosphatase (AP) has been suggested as a biomarker for myocardial dysfunction after Fontan operation. We hypothesized that pediatric patients with myocardial dysfunction requiring orthotopic heart transplant (OHT) have diminished AP compared to normal. A retrospective review was performed in all patients who underwent OHT at Arkansas Children’s Hospital between January 2007 and October 2012. Anatomic diagnoses, therapeutic interventions, and ventricular ejection fraction (EF) were recorded.
Z
scores for AP levels in the study group were determined by comparing the observed AP levels to age- and gender-matched normative values.
T
tests were performed to compare the mean AP
Z
score prior to and after OHT.
p
values |
---|---|
ISSN: | 0172-0643 1432-1971 |
DOI: | 10.1007/s00246-017-1577-x |